RT Journal Article
SR Electronic
T1 Demographic and clinical features associated with in-hospital mortality in Egyptian COVID-19 patients: A retrospective cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.22.21253577
DO 10.1101/2021.03.22.21253577
A1 Asem, Noha
A1 Hassany, Mohamed
A1 Taema, Khaled
A1 Masoud, Hossam
A1 Elassal, Gehan
A1 Kamal, Ehab
A1 Amin, Wagdy
A1 Abdelbary, Akram
A1 Baki, Amin Abdel
A1 Zaky, Samy
A1 Abdalmohsen, Ahmad
A1 Ibrahim, Hamdy
A1 Elnady, Mohamed
A1 Mohamed, Ahmed
A1 Atteia, Ehab
A1 Zaid, Hala
YR 2021
UL http://medrxiv.org/content/early/2021/03/25/2021.03.22.21253577.abstract
AB Introduction Since the worldwide emergence of the COVID-19, several protocols were used by different healthcare organisations. We evaluated in this study the demographic and clinical characteristics of COVID-19 disease in Egyptian population with special consideration for its mortality predictors.Methodology 8162 participants (mean age 48.7±17.3 years,54.5% males) with RT-PCR positive COVID-19 were included. The electronic medical records were reviewed for demographic, clinical, laboratory, and radiologic features. The primary outcome was the in-hospital mortality rate.Results The in-hospital mortality was 11.2%. There was a statistically significant strong association of in-hospital mortality with age >60 years old (OR:4.7; 95% CI 4.1-5.4;p<0.001), diabetes mellitus (OR:4.6; 95% CI 3.99-5.32;p<0.001), hypertension (OR:3.9; 95% CI 3.4-4.5;p<0.001), coronary artery disease (OR:2.7; 95% CI 2.2-3.2;p<0.001), chronic obstructive pulmonary disease (OR:2.1; 95% CI 1.7-2.5;p<0.001), chronic kidney disease (OR:4.8; 95% CI 3.9-5.9;p<0.001), malignancy (OR:3.7; 95% CI 2.3-5.75;p<0.001), neutrophil-lymphocyte ratio >3.1 (OR:6.4; 95% CI 4.4-9.5;P< 0.001), and ground glass opacities (GGOs) in CT chest (OR:3.5; 95% CI 2.84-4.4;P<0.001), respectively. There was a statistically significant moderate association of in-hospital mortality with male gender (OR:1.6; 95% CI 1.38-1.83;p<0.001) and smoking (OR:1.6; 95% CI 1.3-1.9;p<0.001). GGOs was reported as the most common CT finding (occurred in 73.1% of the study participants).Conclusions This multicenter, retrospective study ascertained the higher in-hospital mortality rate in Egyptian COVID-19 patients with different comorbidities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMinistry of health and populationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the research ethics committee and the institutional review board of the Egyptian Ministry of Health and PopulationAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in the manuscript are available